Research shows lovastatin fails to improve Angelman syndrome symptoms in mouse models, highlighting challenges in neurological disorder treatment development.
Discover how proteogenomics is revolutionizing ALS research by revealing how CCNF gene mutations trigger cell death pathways in motor neurons.
Discover how SUMO-associated proteins in the mouse endometrium are dynamically regulated by ovarian hormones throughout the estrous cycle.
Explore how the ubiquitin-proteasome system, the cell's protein degradation machinery, is being targeted for innovative cancer therapies like proteasome inhibitors and PROTACs.
Discover how QTL analysis reveals the genetic secrets of cottonseed traits and their impact on cotton breeding and agriculture.
Discover how USP27X, a deubiquitinating enzyme, is emerging as a promising drug target for lung cancer treatment through innovative research and validation experiments.
Explore how SNIPER(ER) molecules target and degrade ERα proteins in breast cancer treatment through innovative protein degradation technology.
Discover how UBX-306, a novel HPK1 degrader using PROTAC technology, is revolutionizing cancer immunotherapy by eliminating immune system brakes at the molecular level.
Explore how mutations in the MDM2 protein can subvert the body's natural cancer defenses and contribute to tumor development.
Could an eye test one day help predict a brain disorder? New research suggests the answer might be staring back at us.